Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of anaprazole sodium enteric-coated tablets for reflux esophagitis
CTR20222800Phase 2Completed
- Sponsor
- Xuanzhu Biopharmaceutical
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anaprazole sodium in erosive esophagitis (EE), sponsored by Xuanzhu Biopharmaceutical. Started Dec 2022; status: completed.
02
Drugs
anaprazole sodium
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20222800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222800.